RT Journal Article
SR Electronic
T1 IVUS Improves Outcomes with SUPERA Stents for the Treatment of Superficial Femoral-popliteal Artery Disease
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.02.03.23285427
DO 10.1101/2023.02.03.23285427
A1 Prakash Krishnan
A1 Raman Sharma
A1 Sriya Avadhani
A1 Arthur Tarricone
A1 Allen Gee
A1 Serdar Farhan
A1 Haroon Kamran
A1 Annapoorna Kini
A1 Samin Sharma
YR 2023
UL http://medrxiv.org/content/early/2023/02/07/2023.02.03.23285427.abstract
AB Objectives To determine the effect of intravenous ultrasound (IVUS) when used adjunctively with nitinol interwoven bare metal stents in the management of femoropopliteal lesions.Background Nitinol interwoven bare metal stents represent an advancement in stent technology; however nominal deployment remains an area of focus. Intravascular Ultrasound (IVUS) has been shown to improve outcomes in both the coronary and peripheral vasculature by providing the operator with greater vessel detail. The use of adjunctive IVUS with Nitinol bare metal stents has not been widely studied.Methods This study included a cohort of 200 consecutive patients with peripheral artery disease. All patients were treated with ≥1 Supera bare metal stent, and 91 received adjunctive IVUS imaging prior to stent deployment. Deployment conditions of nominal, compressed, and elongated were measured and the primary clinical outcomes included target lesion reintervention, major and minor, below the knee amputation, and mortality.Results The patients who received IVUS had a significantly greater number of nominally deployed stents (p<0.001). Patients who had IVUS imaging also had significantly lower reintervention rates compared to those who did not receive IVUS imaging (p=0.047).Conclusion IVUS and angiography decreases clinically driven target lesion reintervention and increases nominal deployment compared to angiography alone in femoropopliteal lesions treated with interwoven bare metal nitinol stents.Condensed Abstract This retrospective study was done to examine the utility of intravenous ultrasound when used adjunctively for visualization in the management of femoropopliteal lesions in peripheral artery disease patients. There was total of 200 subjects and all were treated using the Supera nitinol self-expanding stent. By the end of the study, the group of subjects treated with intravenous ultrasound had significantly fewer reinterventions and had a greater rate of nominally deployed stents. These findings suggest the beneficial role intravenous ultrasound has compared to angiography alone in the management of femoropopliteal lesions with Supera stents.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialDue to the nature of this studying being retrospective in design, no registration was required.Funding StatementThis study did not receive any external funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Institutional Review Board of the Icahn School of Medicine at the Mount Sinai Hospital: Program of Protection of Human Subjects Committee.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is available on reasonable request.PADPeripheral Artery DiseaseCD-TLRClinically Driven Target Lesion ReinterventionIVUSIntravascular UltrasoundPTAPercutaneous Transluminal AngioplastyDCBDrug Coated Balloon